Skip to content

Envoy Medical COCH Deferred Tax Assets, Net of Valuation Allowance

Deferred Tax Assets, Net of Valuation Allowance at other companies

RDI
Reading International, Inc.RDI
$72.74M+7.8%
Corebridge Financial logo
Corebridge FinancialCRBG
$7.82B-13.6%
Kopin logo
KopinKOPN
$84.25M+0.5%
Rockwell Automation logo
Rockwell AutomationROK
$766M+11.7%
TPG Inc. logo
TPG Inc.TPG
$1.1B+74.1%
Esperion Therapeutics logo
Esperion TherapeuticsESPR
$417.1M+1.0%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsNet.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's deferred tax assets, net of valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's deferred tax assets, net of valuation allowance?
Envoy Medical (COCH) reported deferred tax assets, net of valuation allowance of $808K in Q4 2025.
What is the long-term trend for Envoy Medical's deferred tax assets, net of valuation allowance?
Over 3 years (2022 to 2025), Envoy Medical's deferred tax assets, net of valuation allowance has grown at a -73.7% compound annual growth rate (CAGR), from $44.42M to $808K.